Amphastar Pharma (AMPH) Tops Q3 EPS by 11c

November 8, 2016 4:07 PM EST
Get Alerts AMPH Hot Sheet
Trade AMPH Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.14, $0.11 better than the analyst estimate of $0.03. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.12 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment